SpeeDx announce a collaborative agreement with GSK to supply tests and technology

SYDNEY--(BUSINESS WIRE)--Jun 24, 2019--

SpeeDx Pty. Ltd., a developer of innovative molecular diagnostic solutions, has signed a collaborative agreement with GSK, to provide a combination of existing tests and custom test development to support certain GSK antibiotic clinical trials and new product development.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190624005302/en/

“SpeeDx has a demonstrated commitment to improve patient care, and our tests currently used in clinical practice are supporting Resistance Guided Therapy, positively impacting cure rates and helping to minimise the spread of antimicrobial resistant infections.” Colin Denver, SpeeDx CEO. (Photo: Business Wire)

“We welcome this extension of the utility and application of our tests and technology,” said Colin Denver, SpeeDx CEO. “SpeeDx has a demonstrated commitment to improve patient care, and our tests currently used in clinical practice are supporting Resistance Guided Therapy, positively impacting cure rates and helping to minimise the spread of antimicrobial resistant infections.”

About SpeeDx

Founded in 2009, SpeeDx is an Australian-based private company with offices in Austin and London, and distributors across Europe. SpeeDx specializes in molecular diagnostic solutions that go beyond simple detection to offer comprehensive information for improved patient management. Innovative real-time polymerase chain reaction (qPCR) technology has driven market-leading multiplex detection and priming strategies. Product portfolios focus on multiplex diagnostics for sexually transmitted infection (STI), antibiotic resistance markers, and respiratory disease. For more information about SpeeDx please see: https://plexpcr.com

View source version on businesswire.com:https://www.businesswire.com/news/home/20190624005302/en/

ADVERTISEMENT

CONTACT: Australia, New Zealand and Europe

Madeline O’Donoghue - SpeeDx

+61 406 582 808United States

Rick Roose - RCI Healthcare Public Relations

+1 415 202 4445

KEYWORD: AUSTRALIA/OCEANIA AUSTRALIA

INDUSTRY KEYWORD: MEDICAL SUPPLIES HEALTH MEDICAL DEVICES MANAGED CARE GENERAL HEALTH

SOURCE: SpeeDx Pty. Ltd.

Copyright Business Wire 2019.

PUB: 06/24/2019 08:00 AM/DISC: 06/24/2019 08:01 AM

http://www.businesswire.com/news/home/20190624005302/en

ADVERTISEMENT
Bg pattern light

UPGRADE TO PREMIUM

Subscribe to Samoa Observer Online

Enjoy access to over a thousand articles per month, on any device as well as feature-length investigative articles.

Ready to signup?